Fuda Cancer Hospital
Ovarian cyst treatment cost in China typically depends on the pathology and chosen surgical approach. A laparoscopic ovarian cystectomy runs from $7,200 to $13,500, while more extensive surgery like an oophorectomy costs $7,800 to $17,500. Total expenses vary based on hospital tier and cyst complexity. Patients can save approximately 40-70% compared to the US. Beijing, Shanghai, and Guangzhou are the top cities for these procedures.
Typical Ovarian Cyst Treatment Costs in China
Bookimed Expert Insight: For complex or potentially malignant cysts, specialized oncology centers provide the best security. Fuda Cancer Hospital in Guangzhou is Joint Commission International (JCI) accredited and specializes in minimally invasive therapies. Patients seeking high-capacity facilities should consider Yanda International Hospital near Beijing. It is a Class A Level III facility, the highest tier in China. High-tech centers like these handle 9,000+ operations annually, ensuring high surgical expertise.
| China | Turkey | Austria | |
| Оophorectomy | from $7,800 | from $2,943 | from $15,000 |
| Laparoscopic ovarian cystectomy | from $7,200 | from $2,200 | from $7,000 |
| Hormone therapy | from $3,500 | from $398 | from $7,000 |
No hidden fees – just official clinic prices. Pay at the clinic for Ovarian cyst treatment and use a flexible installment plan if needed.
Bookimed is committed to your safety. We only work with medical institutions that maintain high international standards in Ovarian cyst treatment and have the necessary licenses to serve international patients worldwide.
Bookimed offers free expert assistance. A personal medical coordinator supports you before, during, and after your treatment, solving any issues. You're never alone on your Ovarian cyst treatment journey.
Professor Lin Jinfang is a senior physician and PhD supervisor. She formerly directed the Division of Gynecologic Endocrinology at Fudan University’s Obstetrics and Gynecology Hospital (Red House) in Shanghai. She has more than 40 years of clinical experience. She is a pioneer in gynecologic endocrinology and reproductive medicine and a Lin Qiaozhi Cup honoree.
Focus: complex endocrine infertility; POI and ovarian aging. She developed the "remaining follicle resuscitation" approach. She also treats PCOS, including non-obese types, endometriosis and adenomyosis, amenorrhea, anovulation, and recurrent miscarriage. She provides perimenopausal care, including BHRT, and fertility-preserving minimally invasive surgery such as laparoscopic myomectomy, endometriotic cyst excision, and hysteroscopic septum or polyp resection.
She has published widely on ovarian function preservation and PCOS phenotyping. She mentors future specialists. She also consults at Aiding Women’s Clinic and Kapok Medical in Shanghai.
Professor and Chief Physician. Director of Gynecologic Oncology. PhD in Gynecologic Oncology from the Cancer Hospital, Chinese Academy of Medical Sciences. MSc in Obstetrics and Gynecology from Peking Union Medical College Hospital. Nearly 30 years of clinical experience. Published in SCI and core journals. Co‑author of two gynecologic oncology monographs.
Specializes in standardized diagnosis and comprehensive treatment of ovarian, cervical, and endometrial cancers. Provides surgery, chemotherapy, targeted therapy, immunotherapy, and intraperitoneal hyperthermic perfusion. Pioneer of single‑port laparoscopy at her hospital. Also performs multi‑port laparoscopy, open surgery, and hysteroscopic procedures for benign gynecologic disease.
Affiliations: Youth Director, Chinese Anti‑Cancer Association. Youth Member, Gynecologic Oncology Committee, Fujian Anti‑Cancer Association. Member, Peritoneal Tumor Committee, Fujian Anti‑Cancer Association. Youth Member, Obstetrics and Gynecology Committee, Fujian Medical Association.
Dr. Chen Hong specializes in reproductive endocrinology, infertility treatment, and assisted reproductive technology (ART). She trained for six years under Professor Lin Jinfang, a leading gynecological endocrinology expert in China.
Her clinical focus includes PCOS, premature ovarian insufficiency (POI), recurrent pregnancy loss, recurrent implantation failure, and reproductive immune disorders. She took part in a national multicenter prospective study on lifestyle changes for PCOS. She is also skilled in pelvic floor rehabilitation and management of pelvic floor dysfunction.
Dr. Niu Lizhi is the President and chief surgeon at Fuda Cancer Hospital in Guangzhou. He has performed nearly 10,000 cryosurgeries and 500 NanoKnife procedures. Dr. Niu specializes in minimally invasive oncology for lung, pancreatic, and liver cancers. He treats patients ranging from early childhood through age 94.
Treatment protocols in China utilize integrated diagnostics combining pelvic ultrasound, CA-125 tumor markers, and international IOTA guidelines. Standard care at JCI-accredited Class A level III facilities involves laparoscopic surgery for cysts exceeding 5 cm. Smaller functional cysts typically undergo observation for 1 to 2 menstrual cycles.
Bookimed Expert Insight: Data from major hubs like Beijing and Guangzhou shows that high-volume centers like Yanda International Hospital prioritize rapid imaging. These facilities serve millions of patients annually and often combine international surgical protocols with traditional methods. Patients should expect a lower threshold for surgical intervention than in other countries, particularly if a cyst is persistent or symptomatic.
Patient Consensus: Patients note that doctors usually recommend surgery faster than expected if a cyst looks complex. Many describe the communication as direct, with a clear focus on repeat ultrasounds to decide the treatment path.
Surgery is not always required for ovarian cysts in China. Small or simple cysts often resolve with hormone therapy or a watch and wait approach using repeat ultrasound. Minimally invasive laparoscopic ovarian cystectomy is the preferred surgical option when intervention becomes necessary.
Bookimed Expert Insight: Yanda International Hospital in Beijing operates at Class A Level III. That is the highest clinical ranking available in China. This status typically correlates with high surgical volumes. For example, the facility performs 9,000 operations yearly. This suggests the surgical teams maintain high proficiency in minimally invasive techniques.
Patient Consensus: Patients emphasize asking whether a surgeon can perform a cystectomy to save the ovary. Many prefer the laparoscopic route due to smaller scars and faster returns to daily activity.
Chinese hospitals protect fertility by prioritizing laparoscopic ovarian cystectomy with meticulous tissue preservation. Surgeons utilize single-incision techniques and precision suturing instead of thermal cauterization to prevent egg damage. Top-tier Class A Level III facilities integrate advanced cryopreservation with traditional medical protocols to ensure long-term reproductive health.
Bookimed Expert Insight: Yanda International Hospital holds Class A Level III status, which is the highest tier in China. This classification is rare for hospitals also holding JCI accreditation. Our data shows these facilities manage massive volumes, reaching 2,500,000 patients annually. This high frequency allows surgeons to refine tissue-sparing techniques beyond the capabilities of lower-volume clinics.
Patient Consensus: Patients emphasize choosing specialists who prioritize cystectomy over oophorectomy to protect their future options. They often suggest confirming if a surgeon has extensive experience specifically in fertility-preserving procedures.
Beijing, Shanghai, and Guangzhou are the premier hubs for ovarian cyst surgery in China. Patients should target Grade 3-A public hospitals or JCI-accredited facilities. These centers offer laparoscopic cystectomy and specialized diagnostic imaging. They maintain high safety standards and follow international surgical protocols.
Bookimed Expert Insight: Yanda International Hospital serves over 2,500,000 patients annually and holds Grade 3-A status. This high volume often correlates with refined surgical precision in laparoscopic procedures. Their integration of traditional approaches with international protocols offers a unique recovery framework. For complex cases, choosing a facility with 3,000 beds suggests superior perioperative infrastructure.
Patient Consensus: Patients emphasize choosing university-affiliated 3A hospitals over private clinics for complex surgeries. They note that while consultations feel rushed, the surgeons' experience with high-volume cases provides peace of mind.